about
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administ...
Read More
0.98
-0.02
(-2.00%)
15,297
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Immuron Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..